Home

Disease management

Read time: 5 min

Satellite symposium

Treatment outcomes in schizophrenia – what matters to patients?

Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression...

Read time: 4 min

Satellite symposium

Congress highlights

Patient goals and measuring outcome crucial in MDD

Asking people what they most want from depression treatment, treating to target, measurement-based...

Read time: 3 min

Satellite symposium

Targeting what matters most for patients with depression: Strategies for promoting full functional recovery

Major depression is a common and serious condition with symptoms across domains and being very...

Read time: 3 min

Congress highlights

Brightening mental health for the future

The future of mental health globally will be bright if we make it bright, said a renowned expert in...

Read time: 3 min

Congress highlights

Digital approach to brain disorders needs ethical perspective

With the rapidly expanding frontiers of digital health, as with any move into the/this new...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Could interventions to ensure a good night’s sleep help prevent Alzheimer’s disease?

Sleep disturbance appears to be a risk factor for and an early manifestation of Alzheimer’s...

Read time: 3 min

Aiming for personalized treatment — detecting true-positive subgroups

The ultimate goal for personalized medicine is to prescribe the right treatment for the right...

Read time: 3 min

Patient-reported outcomes — need for more guidance and consistency

Patient-reported outcomes (PROs) are increasingly important for regulators. However, the European...

Read time: 2 min

Congress highlights

Can inflammatory biomarkers help to personalize depression treatment?

Which treatment is best suited for which type of depression? Patients with a subtype of major...

Read time: 4 min

Congress highlights

Early intervention for psychosis: Is it worth the investment?

In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country